Sarang K. Yoon
( out of 20 reviews )

Sarang K. Yoon, DO, MOH

Languages spoken: English

Clinical Locations

Primary Location

South Jordan Health Center

5126 West Daybreak Parkway
South Jordan , UT 84009
801-213-4500
Get Directions

Redwood Health Center

Occupational Medicine
1525 West 2100 South
Salt Lake City , UT 84119
Get Directions

  • Dr. Yoon is an Associate Professor at the University of Utah School of Medicine, Division of Occupational and Environmental Health, and Rocky Mountain Center for Occupational and Environmental Health (RMCOEH). Her responsibilities include research, teaching, administration, and patient care. She is board-certified in Occupational Medicine. She has served as a site PI on a multicenter on COVID-19 vaccine effectiveness in a prospective cohort of frontline workers and children with Centers for Disease Control and Prevention (CDC). She also served as a site PI on a multicenter clinical trial on influenza vaccine efficacy with the CDC. At present, she is conducting an investigator-initiated clinical trial on COVID-19 boosters. In addition to research, she enjoys teaching and mentoring and looks forward to the opportunity further to develop this aspect of scholarship in her career. She practices at the Redwood Clinic in West Valley where she precepts resident physicians and medical students. She is the course director for OEHS 6504 Clinical and Behavioral Aspects of Preventive Medicine. She is the Associate Program Director for the Occupational Medicine Residency. In addition to her clinical and academic responsibilities, she serves as a medical director/occupational health specialist for companies and the federal government to promote worker safety and health.

    Specialties

    Board Certification

    American Board of Preventive Medicine (Occupational Medicine)

    Patient Rating

    4.4 /5
    ( out of 20 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    REDWOOD HEALTH CENTER

    Very kind and attentive, good service [TRANSLATED]

    REDWOOD HEALTH CENTER

    Dr Sarang Kim Yoon is very good.

    REDWOOD HEALTH CENTER

    Dr. Yoon was so kind, communicative, caring, and collaborative. She actively listened, was hands on, and we worked on solutions and care plans together. I really like her!

    REDWOOD HEALTH CENTER

    One of the best doctors there

    REDWOOD HEALTH CENTER

    Very nice

    REDWOOD HEALTH CENTER

    Es muy amable y me entiende en mi situacin y me aclara mis dudas

    REDWOOD HEALTH CENTER

    I really liked her personality. She was very concerned and caring.

    REDWOOD HEALTH CENTER

    took a long time to come back with the bandage and splint

    REDWOOD HEALTH CENTER

    She's very explainable

  • Dr. Yoon is an Associate Professor at the University of Utah School of Medicine, Division of Occupational and Environmental Health, and Rocky Mountain Center for Occupational and Environmental Health (RMCOEH). Her responsibilities include research, teaching, administration, and patient care. She is board-certified in Occupational Medicine. She has served as a site PI on a multicenter on COVID-19 vaccine effectiveness in a prospective cohort of frontline workers and children with Centers for Disease Control and Prevention (CDC). She also served as a site PI on a multicenter clinical trial on influenza vaccine efficacy with the CDC. At present, she is conducting an investigator-initiated clinical trial on COVID-19 boosters. In addition to research, she enjoys teaching and mentoring and looks forward to the opportunity further to develop this aspect of scholarship in her career. She practices at the Redwood Clinic in West Valley where she precepts resident physicians and medical students. She is the course director for OEHS 6504 Clinical and Behavioral Aspects of Preventive Medicine. She is the Associate Program Director for the Occupational Medicine Residency. In addition to her clinical and academic responsibilities, she serves as a medical director/occupational health specialist for companies and the federal government to promote worker safety and health.

    Education history

    Undergraduate Spanish - University of California, Los Angeles B.A.
    Certification Pre-Medical and General Science Studies - University of California, Los Angeles Certificate
    Professional Medical Osteopathic Medicine - Touro University Nevada College of Osteopathic Medicine D.O.
    Internship Internal Medicine - West Anaheim Medical Center Intern
    Graduate Training Occupational Health - University of Utah School of Medicine M.O.H.
    Residency Occupational Medicine - University of Utah School of Medicine Resident
    Chief Resident Occupational Medicine - University of Utah School of Medicine Chief Resident

    Selected Publications

    Journal Article

    1. Lutrick K, Groom H, Fowlkes AL,..., Yoon SK (2022). COVID-19 Vaccine Perceptions and Uptake in a National Prospective Cohort of Essential Workers. Vaccine, 40(3), 494-502.
    2. Tyner HL, Burgess JL, Grant MS,..., Yoon SK,...et al. (2021). Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of Natural Infection. Clin Infect Dis, 75(1), e827-e837.
    3. Thompson MG, Burgess JL, Naleway AL, Tyner HL, Yoon SK, et al. (2021). Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021. MMWR Morb Mortal Wkly Rep, 70(13), 495¿500.
    4. Fowlkes A, Gaglani M, Groover K,..., HEROES-RECOVER Network (2021). Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021. MMWR Morb Mortal Wkly Rep, 70(34), 1167-1169.
    5. Thompson MG, Burgess JL, Naleway AL, Tyner H, Yoon SK, et al (2021). Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. New England Journal of Medicine (International Edition), 385(4), 320-329. (Read full publication)
    6. Yoon SK, Thiese MS, Ott U, Kapellusch J, Merryweather A, Wood EM, Ronna BB, Foster J, Drury DL, Hegmann K (2019). The Role of Elbow Tender Point Examination in the Diagnosis of Lateral Epicondylitis. . Journal of occupational and environmental medicine, 61(2), 126-131.
    7. Edwards LJ, Fowlkes AL, Wesley MG,...Yoon SK,...et al (2021). Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): study design and methods for a multi-site longitudinal cohort . JMIR research protocols, 10(12), e31574.
    8. Naleway AL, Grant L, Caban-Martinez AJ,...Yoon SK,...et al (2022). Incidence of SARS-CoV-2 infection among COVID-19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January-September 2021. Influenza and other respiratory viruses, 16(3), 585-593.
    9. Lutrick K, Rivers P, Yoo YM, ...Yoon SK,...et al (2021). Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021. MMWR. Morbidity and mortality weekly report, 70(5152), 1761-1765.
    10. Yoon SK, Hegmann KT, Thiese MS,...HEROES-RECOVER Network Investigator (2022). Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers . New England Journal of Medicine (International Edition), 386(19), 1855-1857.
    11. Fowlkes AL, Yoon SK, Lutrick K, et al (2022). Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022. MMWR. Morbidity and mortality weekly report, 71(11), 422-428.
    12. Burns J, Rivers P, LeClair LB, ...Yoon SK,...et al (2022). Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): Protocol for a Multisite Longitudinal Cohort Study. JMIR research protocols, 11(7), e37929.
    13. Thompson MG, Yoon SK, Naleway AL,...HEROES-RECOVER Network Investigator (2022). Association of mRNA COVID-19 Vaccination with Clinical and Virologic Features of COVID-19 among US Essential and Frontline Workers . JAMA, 328(15), 1523-1533.
    14. Veguilla V, Fowlkes AL, Bissonnette A,...,Yoon SK,...et al (2022). Detection and Stability of SARS-CoV-2 in Three Self Collected Specimen Types: flocked midturbinate swab (MTS) in viral transport media, foam MTS, and saliva. Microbiology spectrum, 10(3), e0103322.
    15. Lutrick K, Rivers P, Fowlkes AL,..., Yoon S (2022). Parental Intentions and Perceptions Toward COVID-19 Vaccination Among Children Aged 4 Months to 4 Years - PROTECT Cohort, Four States, July 2021-May 2022. MMWR Morb Mortal Wkly Rep, 71(35), 1109-1114.
    16. Ellingson KD, Hollister J, Porter C,...Yoon SK,...et al (2023). Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers. Emerging infectious diseases, 29(3), 599-604.
    17. Herring MK, Romine JK, Wesley MG,...Yoon SK...et al (2022). Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses. Clinical infectious diseases, 76(10), 1822-1831.
    18. Lyski ZL, Porter C, Uhrlaub JL,...Yoon SK,...et al (2023). Humoral Immune Response to mRNA COVID-19 Vaccination Among Children 5-11 in a Multisite Prospective Cohort study. Open forum infectious diseases, 10(8), ofad431.
    19. Hollister J, Caban-Martinez AJ, Ellingson KD,...Yoon SK...,et al (2023). Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies. . Environmental research, Epub 2023 Oct 8,
    20. Rivers P, Porter C, LeClair LB,...Yoon SK, Lutrick K (2024). Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study. Vaccine, Epub ahead of print,
    21. Feldstein LR, Britton A, Grant L,...Yoon SK,...et al (2024). Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years. JAMA, 331(5), 408-416.

    Book Chapter

    1. Mumenthaler S, Yoon NK, Li A, Mah V, Chang G, Nooraie F, Elshimali Y, Hanna S, Kim S, Horvath S, Apple S, Chia D, Seligson DB, Goodglick (2008). Tissue Microarrays: Construction and Utilization For Biomarker Studies.

    Letter

    1. Thompson MG, Grant L, Meece J, HEROES-RECOVER Networ (2021). Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. Reply. New England Journal of Medicine (International Edition), 385(19), 1819-1821.

  • News & Podcasts

    News